Literature DB >> 11836336

11beta-hydroxysteroid dehydrogenase type 2 is expressed in the human kidney glomerulus.

Saeko Kataoka1, Akihiko Kudo, Hiroshi Hirano, Hayato Kawakami, Toshio Kawano, Eiji Higashihara, Hirotoshi Tanaka, Francoise Delarue, Jean-Daniel Sraer, Tomoatsu Mune, Zygmunt S Krozowski, Kunimasa Yan.   

Abstract

Our previous study demonstrated that the GR is expressed in the human kidney glomerulus. The function of the GR of glomerular cells might be affected by the concentration of intracellular glucocorticoids, which is modulated by 11beta-hydroxysteroid dehydrogenase type 2 (11betaHSD2). Because the expression of 11betaHSD2 in the glomerular cells remains unclear, we used competitive RT-PCR and immunoblotting to detect the expression of 11betaHSD2 mRNA and protein in isolated human glomeruli, in whole kidney cortex as a positive control, and in a human glomerular visceral epithelial cell line. 11betaHSD2 mRNA was detected in all samples. Specific antihuman 11betaHSD2 antibody recognized a single band at 41 kDa, consistent with the molecular mass of human 11betaHSD2, in the samples of the isolated glomeruli and whole kidney cortex. Furthermore, definite 11betaHSD2 enzymatic activity was also determined with the sample of isolated glomeruli. We also performed immunohistochemistry by light and electron microscopy to determine the cellular and subcellular localization of 11betaHSD2 in the human glomeruli. Immunoreactivity of the enzyme was clearly observed in the glomerular visceral epithelial cells and endothelial cells as well as in the distal convoluted tubules and collecting ducts. The subcellular localization of 11betaHSD2 was shown to be endoplasmic reticulum. These results suggest that 11betaHSD2 might play a crucial role in modulating the intracellular concentration of glucocorticoids in human glomerular cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11836336     DOI: 10.1210/jcem.87.2.8257

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

Review 1.  Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome.

Authors:  Miki Nagase
Journal:  Clin Exp Nephrol       Date:  2010-06-09       Impact factor: 2.801

2.  Increased glucocorticoid metabolism in diabetic kidney disease.

Authors:  Daniel Ackermann; Bruno Vogt; Murielle Bochud; Michel Burnier; Pierre-Yves Martin; Fred Paccaud; Georg Ehret; Idris Guessous; Belen Ponte; Menno Pruijm; Antoinette Pechère-Bertschi; Heidi Jamin; Rahel Klossner; Bernhard Dick; Markus G Mohaupt; Carine Gennari-Moser
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

3.  Amino acid transporter LAT3 is required for podocyte development and function.

Authors:  Yuji Sekine; Yukino Nishibori; Yoshihiro Akimoto; Akihiko Kudo; Noriko Ito; Daisuke Fukuhara; Ryota Kurayama; Eiji Higashihara; Ellappan Babu; Yoshikatsu Kanai; Katsuhiko Asanuma; Michio Nagata; Arindam Majumdar; Karl Tryggvason; Kunimasa Yan
Journal:  J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 10.121

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.